Gray/White Matter Contrast in Parkinson’s Disease

Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Aging Neurosci
Main Authors: Uribe, Carme, Segura, Barbara, Baggio, Hugo C., Abos, Alexandra, Garcia-Diaz, Anna I., Campabadal, Anna, Marti, Maria J., Valldeoriola, Francesc, Compta, Yaroslau, Bargallo, Nuria, Junque, Carme
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Neuroscience
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881246/
https://ncbi.nlm.nih.gov/pubmed/29636679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00089
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki